BSE filing, NSE: SSORGS. Summary written from the filing by ALFA Finder's alert engine.
Oxygenta Pharmaceutical Ltd: key numbers
- Share price
- ₹46.50
- Market cap
- ₹172.0 Cr
- Revenue (annual)
- ₹113.0 Cr
- Net profit (annual)
- ₹-17.57 Cr
- P/E (TTM)
- -12.7×Sector 37.9×
- Promoter holding
- 56.54%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Oxygenta Pharmaceutical Ltd
All →Oxygenta Pharmaceutical Board Meeting Date
Oxygenta Pharmaceutical Limited has scheduled a board meeting for November 10, 2026. The board will primarily consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026.
Oxygenta Pharmaceutical Other Announcement
The company filed its quarterly shareholding pattern as mandated under Regulation 31(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Oxygenta Pharmaceutical Acquisition Worth ₹6.75 Cr
Oxygenta Pharmaceutical acquired land in Telangana from TGIIC for Rs. 6.75 Crore. The purchase supports business expansion and long-term strategic infrastructure needs.
- Value
- ₹6.75 Cr
Oxygenta Pharmaceutical Annual General Meeting
Oxygenta Pharmaceutical Limited conducted its 33rd Annual General Meeting on August 21, 2026, via video conferencing to discuss and adopt various corporate business resolutions.
Oxygenta Pharmaceutical Annual Report
Oxygenta Pharmaceutical has submitted its 33rd Annual Report for FY 2025-26, including the notice for the upcoming Annual General Meeting scheduled for August 21, 2026.
Oxygenta Pharmaceutical Annual General Meeting
Oxygenta Pharmaceutical Limited announced its 33rd Annual General Meeting scheduled for August 21, 2026. The notice includes director appointments and adoption of the company's financial statements.
Other board meeting date announcements
All →Covance Softsol Board Meeting Date
Covance Softsol will hold a board meeting on November 10, 2026 to consider unaudited quarterly results for September 2026. Date is proposed; agenda is not yet approved.
Rashtriya Chemicals & Fertilizers Board Meeting Date
Rashtriya Chemicals and Fertilizers Limited intimated a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. Trading window closes from 1 October 2026 to 14 November 2026.
Aureate Tradde Board Meeting Date
Aureate Tradde will hold a board meeting on November 14, 2026 to consider unaudited half-year results for September 2026. Date is proposed; agenda is not yet approved.
Bihar Sponge Iron Board Meeting Date
Bihar Sponge Iron will meet on 13 November 2026 to consider unaudited standalone quarterly results for September 2026. Trading window closes from 1 October 2026 until 16 November 2026.
Madala Holdings Board Meeting Date
Madala Holdings will meet on 10 November 2026 to consider unaudited standalone quarterly results for September 2026. Trading window closes from 1 October 2026 until 16 November 2026.
Mudunuru Board Meeting Date
Mudunuru will meet on 12 November 2026 to consider standalone quarterly results, fund raising and other business. Trading window closes from 1 October 2026.